On common, individuals with psychosis die 15 years sooner than the final inhabitants. That is largely attributable to preventable bodily diseases, with weight problems taking part in a central position (Plana-Ripoll O et al, 2019). Weight problems is round 3 times extra frequent in individuals with psychosis in comparison with the final inhabitants (Afzal M et al, 2021). Earlier analysis has proven that whereas antipsychotic medicines are important to help restoration, they’re a key contributor to this subject (Johnston G, 2025; Pillinger T et al, 2020).
Prediction fashions like PsyMetRiC (Perry BI et al, 2026) are useful to determine danger of future bodily well being issues, which might inform younger individuals with psychosis together with their medical groups. Nevertheless, these fashions usually are not capable of unravel what really causes these points and methods to stop them.
This new research by Leighton et al. (2026) makes an attempt to bridge this hole. The authors explored whether or not early weight acquire within the first 12 weeks of antipsychotic remedy causes weight problems after 1 12 months, and whether or not we will use causal prediction fashions to know what would occur for a person if we intervened.
Understanding early weight acquire within the first weeks of antipsychotic remedy may assist stop long-term bodily well being inequalities in psychosis.
Strategies
This research used information from a randomised managed trial evaluating olanzapine and haloperidol in individuals with first-episode psychosis.
The authors performed two foremost analyses:
- Causal mediation evaluation (n=97) to check whether or not weight acquire at 1 12 months is mediated by early (0-12 weeks) versus later (12-52 weeks) weight change.
- Prediction modelling, growing two sequential logistic regression fashions:
- A baseline mannequin predicting ≥7% weight acquire at 12 weeks (n=172)
- A 12-week mannequin predicting weight problems at 1 12 months (n=97)
In addition they used counterfactual modelling to estimate how altering remedy or early weight would possibly alter outcomes.
Outcomes
Pattern and outcomes
The baseline mannequin included 172 members. On this group, 57% skilled clinically important weight acquire (≥7%) at 12 weeks. The 12-week mannequin included 97 members, of whom 36% developed weight problems at 1 12 months.
Causal mediation
The entire impact of olanzapine in comparison with haloperidol on 1-year weight was 6.62 kg (95% CI 1.44 to 12.3). Most of this impact was defined by weight acquire within the first 12 weeks (5.70 kg; 95% CI 2.83 to eight.66). There was no robust proof that later weight acquire between 12-52 weeks performed a significant mediating position.
General, long-term variations in weight seem like pushed largely by early adjustments fairly than later weight acquire.
Prediction mannequin efficiency
The fashions distinguished properly between individuals with greater and decrease danger of clinically important weight acquire/weight problems. Nevertheless, their predictions are overly optimistic, showcasing patterns of under-estimating sufferers’ danger. Particularly:
- Baseline mannequin (12-week clinically important weight acquire):
- C-index: 0.728 (good discrimination)
- Calibration slope: 0.768 (some overfitting)
- 12-week mannequin (1-year weight problems):
- C-index: 0.904 (excellent discrimination)
- Calibration slope: 0.601 (notably overfitted)
Counterfactual predictions
Switching from olanzapine to haloperidol diminished danger of early weight acquire. Lowering weight acquire inside the first 12 weeks lowered predicted danger of growing weight problems inside 1 12 months.
Which means that if a affected person good points a number of weight early into remedy, intervening shortly may change their long-term trajectory.
Utilizing mediation evaluation and prediction modelling, the research confirmed that early weight acquire within the first 12 weeks of remedy defined a lot of the distinction in longer-term weight outcomes.
Conclusions
The authors concluded that:
Early weight acquire within the first 12 weeks of antipsychotic remedy could causally mediate weight outcomes at 1 12 months.
In addition they show the feasibility of causal prediction fashions, which might estimate how remedy adjustments or adjustments in early weight trajectories would possibly alter outcomes for people.
Nevertheless, these fashions usually are not but prepared for medical use, attributable to small pattern sizes in mannequin growth and a scarcity of exterior validation. The findings are greatest seen as hypothesis-generating, pointing towards the potential of causal prediction modelling fairly than instruments for present medical decision-making.
Early weight trajectories could affect 1-year outcomes, however though causal prediction fashions are possible, they aren’t but prepared for follow.
Strengths and limitations
That is an formidable and methodologically progressive research utilizing randomised managed trial information. This reduces the impression of confounding by indication, the place clinicians in routine follow select remedies primarily based on affected person traits. As the identical traits may additionally affect outcomes, confounding by indication makes it troublesome to separate true remedy results from variations between sufferers. Using randomised trial information on this research helps stability these traits throughout remedy teams and subsequently strengthens claims of causality, which means variations in outcomes usually tend to mirror the remedy itself fairly than pre-existing variations between sufferers.
Nevertheless, a number of points restrict the impression of those findings:
- The pattern is small, particularly for the 12-week and mediation analyses (n=97)
- There may be substantial, unbalanced dropout throughout the 2 arms.
- Miscalibration is seen in each fashions.
Collectively, these limitations elevate considerations about attrition bias and overfitting, making it much less doubtless that this mannequin will generalise to different sufferers.
Extra typically, whereas causal prediction fashions provide a step ahead from conventional danger prediction, they themselves include essential limitations. They depend on robust assumptions in regards to the underlying causal construction: if these are incorrect, the ensuing predictions and steered interventions could also be deceptive. As such, these approaches require massive, high-quality datasets to precisely mannequin this causal construction. Nevertheless, this then implies that these datasets could not mirror real-world medical samples. Randomised managed trial information solely characterize round 20% of individuals with psychosis, as many have bodily well being comorbidities that result in trial exclusion (Taipale H et al., 2022).
Causal prediction fashions additionally stay weak to unmeasured confounding (e.g. life-style or organic elements), which might bias estimates even in well-designed analyses (although the authors of the present paper mitigated this with sensitivity analyses).
A key problem is that counterfactual predictions, that are central to those fashions, can’t be straight validated on the particular person degree. This limits confidence in individual-level “what if” medical situations.
This research advantages from randomised information for causal inference, however sensible and methodological limitations in modelling, generalisability, and unverifiable counterfactuals imply findings stay exploratory.
Implications for follow
So, what does this imply for real-world care?
1. Timing is all the pieces
Beginning antipsychotic remedy can shortly result in substantial weight acquire. This echoes earlier research displaying that individuals with first episode psychosis gained 3.5kg on common inside the first 35 days of remedy (Vochoskova Okay et al. 2023).
* The primary 12 weeks of antipsychotic remedy are essential *
If early weight acquire drives later weight problems, then ready months or years to intervene is simply too late. Companies ought to prioritise:
- Early weight monitoring (weekly/fortnightly)
- Early entry to dietary or life-style help
- Proactive discussions about weight danger earlier than beginning remedy
2. Rethinking remedy selections
The findings additionally elevate questions on antipsychotic alternative. Whereas olanzapine could also be more practical or higher tolerated in some instances, its metabolic dangers are substantial.
This research suggests:
- Therapy selections ought to explicitly weigh psychiatric profit vs bodily well being dangers
- Shared decision-making is essential: sufferers ought to perceive these trade-offs and have enter through which unwanted side effects they view as most essential to keep away from.
3. Towards precision psychiatry
Maybe essentially the most thrilling implication is the potential for causal, individualised prediction fashions. By use of causal prediction fashions, we will predict not simply danger, however what would occur if we intervened. This framework doesn’t have to act in opposition with associative prediction fashions (e.g. PsyMetRiC), however may inform medical resolution making to scale back the impression of recognized dangers and optimising look after individuals with psychosis.
General, whereas the research makes use of novel and acceptable strategies, the findings ought to be interpreted cautiously, as an alternative demonstrating the feasibility and the potential of causal prediction fashions in psychiatry.
Early antipsychotic remedy can quickly improve weight, highlighting the necessity for early monitoring, knowledgeable prescribing selections, and the potential position of prediction fashions in guiding personalised danger and remedy in psychosis care.
Assertion of pursuits
Dominic Oliver is a part of the PsyMetRiC Working Division in partnership with College of Birmingham Enterprise however derives no monetary profit. Generative AI was used for modifying functions.
Editor
Edited by Éimear Foley. AI instruments assisted with language refinement and formatting throughout the editorial section.
Hyperlinks
Major paper
Samuel Leighton, I Lam Leong, Damian Machlanski, Benjamin Perry, Sotirios Tsaftaris, Fani Deligianni, Stephen Lawrie, Rajeev Krishnadas (2026) Antipsychotic-induced weight acquire in psychosis: causal mediation evaluation and feasibility research of causal actionable prediction mannequin growth utilizing counterfactuals to focus on weight problems. British Journal of Psychiatry. Printed on-line 2026:1-10. doi:10.1192/bjp.2026.10561
Different references
Afzal M, Siddiqi N, Ahmad B et al. (2021) Prevalence of Chubby and Weight problems in Individuals With Extreme Psychological Sickness: Systematic Evaluate and Meta-Evaluation. Entrance. Endocrinol. 12:769309. doi: 10.3389/fendo.2021.769309
Johnston G (2025) Fast weight acquire after SMI prognosis, however why so few referrals for help? The Psychological Elf, 2 Dec 2025.
Perry BI, Osimo EF, Si S. et al. (2026) Cardiometabolic prediction fashions for younger individuals with psychosis spectrum issues within the UK (PsyMetRiC 2.0): a retrospective, multicohort medical prediction mannequin research. Lancet Psychiatry 2026 13 (4) 291-303 https://doi.org/10.1016/S2215-0366(25)00398-0
Pillinger T, McCutcheon RA, Vano L. et al. (2020) Comparative results of 18 antipsychotics on metabolic perform in sufferers with schizophrenia, predictors of metabolic dysregulation, and affiliation with psychopathology: a scientific evaluation and community meta-analysis. Lancet Psychiatry 2020 7 (1) 64-77. https://doi.org/10.1016/S2215-0366(19)30416-X
Plana-Ripoll O, Pedersen CB, Agerbo E, et al. A complete evaluation of mortality-related well being metrics related to psychological issues: a nationwide, register-based cohort research. Lancet 2019; 394: 1827–35; DOI: 10.1016/S0140-6736(19)32316-5
Taipale H, Schneider-Thoma J, Pinzón-Espinosa J. et al. (2022) Illustration and outcomes of people with schizophrenia seen in on a regular basis follow who’re ineligible for randomized medical trials. JAMA Psychiatry 2022 79 (3) 210-218. https://doi.org/10.1001/jamapsychiatry.2021.3990
Vochoskova Okay, McWhinney SR, Fialova M, et al. Weight and metabolic adjustments in early psychosis-association with each day quantification of remedy publicity throughout the first hospitalization. Acta Psychiatr Scand. 2023 148 265–276. https://doi.org/10.1111/acps.13594
